Trial Profile
Open-labelled, multicenter study of pazopanib eye drops in subjects with neovascular age-related macular degeneration.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 27 Nov 2015 New trial record